Clinical Scorecard: Narrow DCIS Margins May Not Always Warrant Reexcision
At a Glance
| Category | Detail |
|---|---|
| Condition | Ductal Carcinoma In Situ (DCIS) |
| Key Mechanisms | Association of margin width with ipsilateral breast tumor recurrence (IBTR) rates. |
| Target Population | Postmenopausal patients with hormone receptor-positive DCIS. |
| Care Setting | Breast-conserving surgery and whole-breast irradiation. |
Key Highlights
- Narrower negative margins correlated with slightly higher 10-year IBTR rates.
- Margin width not statistically significant for recurrence after adjustment for confounding factors.
- Current guidelines recommend a 2-mm negative margin for DCIS.
- Omission of reexcision for narrow margins may be reconsidered in selected patients.
- Tumor size remains a significant factor for recurrence risk.
Guideline-Based Recommendations
Diagnosis
- Assess margin width in patients undergoing breast-conserving surgery.
Management
- Consider personalized decision-making regarding reexcision based on margin width.
Monitoring & Follow-up
- Monitor for ipsilateral breast tumor recurrence in patients with narrow margins.
Risks
- Higher recurrence risk associated with larger tumor size.
Patient & Prescribing Data
Postmenopausal patients with hormone receptor-positive DCIS.
65% completed 5 years of endocrine therapy, adherence did not differ by margin group.
Clinical Best Practices
- Follow current consensus guidelines for margin width in DCIS.
- Evaluate genomic profiles for recurrence risk assessment.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
